Key Highlights

  • MetaOptics proposes to offer 3 million ADSs at $5 to $7 each on Nasdaq.
  • FY2025 revenue rose 891% to S$787,388 from a very low prior-year base.
  • Net loss widened to S$5.4 million as listing costs and R&D spending increased.

A small Singapore company with a large ambition is testing investor appetite on Wall Street. MetaOptics Ltd, already listed on the SGX Catalist Board under ticker 9MT since September 2025, has filed a Form F-1 registration statement with the U.S. Securities and Exchange Commission for a proposed dual listing of American Depositary Shares on the Nasdaq Capital Market under the proposed ticker "MOT." If the MetaOptics IPO clears regulatory review and finds buyers at its indicated price range, it would mark a significant moment for Singapore stocks in the global optics sector — and for the emerging science of metalenses, which MetaOptics has staked its future on. This article sets out what is publicly confirmed, what remains uncertain, and what investors tracking this deal should be watching.

What Happened

MetaOptics first came to public markets in September 2025, raising S$6 million through a placement of 30 million shares at S$0.20 each on the SGX Catalist Board. The offering was fully subscribed and gave the company a post-IPO market capitalisation of approximately S$47 million at listing. The company then announced plans to pursue a Nasdaq dual listing in November 2025, a move shareholders approved at an extraordinary general meeting on 10 April 2026.

On 4 May 2026, MetaOptics filed the initial Form F-1 registration statement with the SEC. The company subsequently filed amended F-1/A documents. According to the most recent amended filings reviewed, MetaOptics proposes to offer 3,000,000 ADSs (or up to 3,450,000 ADSs if underwriters exercise a standard over-allotment option in full), with an indicated price range of US$5.00 to US$7.00 per ADS. Roth Capital Partners and The Benchmark Company are named as representatives of the underwriters. At the midpoint of the indicated range, the gross proceeds would amount to approximately US$18 million before fees and expenses. The final offering size, price, and timeline have not been confirmed as of the time of publication. The registration statement has been filed but is not yet effective, meaning no ADSs may be legally sold until the SEC declares it effective.

The company has simultaneously maintained its ordinary share listing on the SGX Catalist Board, where shares traded at approximately S$0.86 as of mid-May 2026, according to a contemporaneous SEC filing.

Why It Matters

The proposed Nasdaq listing would make MetaOptics one of very few Singapore-headquartered technology companies to pursue a concurrent dual listing on SGX and the Nasdaq in the same capital-markets cycle. The move is notable for several reasons. First, it tests whether U.S. institutional and retail investors will fund a micro-cap advanced optics company at the early-revenue stage. Second, it signals a strategic pivot toward North America as both a capital source and a customer base: MetaOptics has incorporated a U.S. subsidiary and joined Stanford Engineering's SystemX Alliance program, a consortium supporting applied research in technology systems. Third, the deal arrives at a moment when the photonics and metalens sector is attracting heightened attention from the semiconductor and consumer electronics supply chain, given the race to miniaturize optical components for AI data centers, augmented reality headsets, and next-generation smartphones.

For followers of Singapore stocks and the broader stock market today, the MetaOptics IPO represents an early test case of how Catalist-listed companies can use Nasdaq's reach to widen their investor base without abandoning their home exchange.

Company Overview

MetaOptics Ltd was incorporated in Singapore and is registered in the Cayman Islands for holding purposes. The company describes itself as a "vertically integrated metalens designer and manufacturer," and it is important here to distinguish terminology: MetaOptics the company is built around what the scientific and engineering community calls "meta-optics" or "metalenses" — flat, nanostructured optical elements that use arrays of sub-wavelength structures to bend and focus light, replacing the curved glass lenses traditionally found in cameras, sensors, and displays. MetaOptics does not make conventional curved glass lenses; its core product is the glass-based flat metalens, manufactured using a 12-inch deep ultraviolet (DUV) lithography process similar to that used in semiconductor fabrication.

The company organises its business into four segments. The metalens equipment group sells advanced metalens production machines, including the company's direct laser writer, metalens automatic testers, and assembly equipment. The metalens foundry division fabricates custom metalenses on contract. The metalens products group develops finished consumer and industrial devices — including a metalens-equipped 5G smartphone prototype, pico projectors, and smart glasses with 3D gesture recognition. A fourth group, MetaOptics AI, develops 3D biometric, gesture recognition, and IoT imaging algorithms designed to work in conjunction with metalens optics.

The company's target markets span co-packaged optics (CPO) for data centers, mobile communications, augmented and virtual reality, automotive sensing, AI semiconductor manufacturing, and consumer electronics. Executive Chairman Thng Chong Kim oversees strategy and business development. A new Chief Executive Officer, Aloysius Chua Hao Peng, was appointed as part of a succession planning process to lead commercial execution.

Financial and Market Context

MetaOptics released its inaugural annual results as a listed company on 28 February 2026, covering the financial year ended 31 December 2025. Revenue for FY2025 was S$787,388 — an increase of 891% compared to S$79,440 in FY2024. The growth figure is striking but should be read carefully. The base was extremely low: just S$79,440 in revenue during the prior year. The FY2025 uplift was driven primarily by two factors: the delivery of a single direct laser writer to a customer in Taiwan, which enabled metalens prototyping and fabrication in that country's semiconductor supply chain; and higher aggregate sales of metalens products and modules to customers globally, used largely for evaluation and integration testing rather than volume production at this stage.

Gross profit in FY2025 was S$159,826, up 502% from S$26,569 in FY2024, implying a gross margin of approximately 20%. Net loss for FY2025 widened to S$5.4 million from S$1.95 million the prior year. Management attributed the wider loss to three categories of expense: approximately S$2.4 million in one-off professional fees related to the SGX Catalist IPO and the proposed Nasdaq dual listing; approximately S$1 million in non-cash items including depreciation and finance expenses; and approximately S$1.8 million in research and development spending tied to new product launches, including the generation-2 products shown at CES 2026 in January.

The company had a cash position of approximately S$2.9 million from operating resources plus S$4.8 million of uninvested IPO and placement proceeds, for a combined liquidity pool of roughly S$8.8 million as of the reporting date. The proposed Nasdaq ADS offering, if completed, aims to raise at least an additional US$15 million according to the company's stated objectives, which would substantially bolster the balance sheet.

On the market side, independent research cited in the company's SGX prospectus projected that the global metalens market could grow at a compound annual growth rate of approximately 74.8% between 2024 and 2029, reaching US$493 million in market size by 2029. These are third-party projections and cannot be independently verified here; they reflect an early-stage technology sector where forecasts carry significant uncertainty.

Bullish Factors

Several aspects of the MetaOptics story could attract investor interest. The technology itself sits at a genuine inflection point. Metalenses are not a speculative concept; they are demonstrably manufacturable using existing semiconductor-grade DUV lithography equipment, and MetaOptics' use of 12-inch wafer processes suggests it is building to a scaling pathway consistent with industrial production rather than laboratory-only output. The elimination of the camera bump — the protruding lens module on modern smartphones — is a tangible consumer benefit that device makers and their customers have long sought, and MetaOptics has publicly stated this is one of its design goals.

The company's CES 2026 product showcase, where it presented five metalens-powered devices including a smartphone prototype and smart glasses with 3D gesture recognition, generated documented customer interest and feedback, according to company statements. A non-binding memorandum of understanding with a camera module manufacturer to produce metalens camera and optical modules has also been reported, though the identity of that partner has not been publicly confirmed.

The Stanford Engineering SystemX Alliance membership and the U.S. subsidiary incorporation provide credibility for the North American customer push. The dual listing structure, if completed, would allow MetaOptics to tap U.S. growth investors while retaining the governance and listing infrastructure already in place on SGX. The indicated ADS price range of US$5.00–US$7.00 implies a market capitalisation that, depending on the final share count and exchange rate, would likely remain in micro-cap territory, creating room for growth if commercial traction materializes.

Bearish Risks

The risks are substantial and investors should weigh them with care.

Revenue quality is the first concern. FY2025 revenue of S$787,388 is not just small in absolute terms — it was also heavily concentrated. A significant portion derived from a single equipment sale to a single customer in Taiwan. That is not a recurring revenue stream, and it is not the kind of volume production revenue that investors typically value in a manufacturing company. The FY2024 base was S$79,440. While the 891% growth rate will feature prominently in any marketing of the deal, the underlying revenue trajectory from prototyping-stage sales to production-volume contracts has not yet been demonstrated.

Customer concentration risk is closely related. MetaOptics has not publicly disclosed how many paying customers it has or what share of revenue any single customer represents. When a substantial portion of annual revenue can be traced to one equipment shipment, investors face binary execution risk on the next comparable deal.

The net loss trajectory is also a concern. The S$5.4 million net loss in FY2025 reflected S$2.4 million in one-off IPO costs that should not recur at the same scale, but the underlying R&D and operating cost base remains well above the revenue line. The company is in a pre-commercial ramp phase, and the path to profitability is uncertain and has not been publicly guided.

Geopolitical and supply chain exposure adds another layer. MetaOptics sources its manufacturing capability from semiconductor supply chains that span Singapore, Taiwan, and now the United States — regions subject to shifting trade policy, technology export controls, and semiconductor access restrictions. Given the ongoing sensitivity around DUV lithography equipment and the broader semiconductor technology rivalry between the U.S. and China, any escalation in export controls could affect the company's equipment business or access to fabrication tools.

Finally, the metalens sector itself faces competitive risk. While MetaOptics claims to be the first pure-play publicly listed metalens company, the underlying science is being pursued by well-funded university spin-outs, large optics conglomerates, and semiconductor companies that could enter the space with resources MetaOptics cannot match at this stage.

What Investors Are Watching Next

The SEC registration statement effectiveness date is the immediate binary event. Until the SEC declares the F-1 effective, no ADS transaction can occur legally, and the offering could be delayed, modified, or withdrawn. Investors should monitor EDGAR filings under MetaOptics' SEC registrant number (CIK 0002099681) for any further amendments or the final prospectus.

Beyond the mechanics of the offering, the most important commercial indicators to watch are: the signing of binding customer contracts for metalens volume production (rather than evaluation sales); the delivery of additional direct laser writers or foundry equipment, which carry higher revenue per transaction; any announcement of a named major customer in the smartphone, AR/VR, or CPO space; and updates on the U.S. subsidiary's customer pipeline following its establishment and the Stanford SystemX membership.

Separately, the SGX-traded shares (9MT) provide a real-time proxy for market sentiment on the company ahead of the Nasdaq listing. As of mid-May 2026, the S$0.86 price implies a meaningful premium to the S$0.20 placement price at the September 2025 SGX IPO, suggesting early post-listing demand — though the stock's limited liquidity on Catalist makes that price signal noisy.

Underwriters Roth Capital Partners and The Benchmark Company will be the key intermediaries managing the book-building process; their progress in securing institutional orders will be a leading indicator of whether the deal prices within or outside the indicated range.